Brendan Carolan is a Respiratory physician. OpenAlex indexes 22 publications with 895 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
191 Bedford Street
Fall River, MA 027213050
Telephone
508-679-4239Registry record last updated 9 Mar 2015.
Industry payments
38 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202516 payments
- GENZYME CORPORATIONProgram year202513 payments
- GlaxoSmithKline, LLC.Program year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
84.2%Corticosteroid46.8%Trelegy Ellipta32%Breztri Aerosphere23%Fluticasone Propionate18%Breo Ellipta11%Symbicort5%Budesonide-Formoterol Fumarate4%Dulera3%Arnuity Ellipta1%Breyna1%Budesonide1%Fluticasone-Vilanterol1%Part D<11 patientsbeta2-Adrenergic Agonist20.8%Albuterol Sulfate Hfa81%Ventolin Hfa17%Formoterol Fumarate2%Part D<11 patients+ 7 more classes in this area
Metabolism & gastrointestinal
8.8%Corticosteroid4.2%Prednisone100%Part D≥83 patientsProton pump inhibitor3.7%Omeprazole82%Pantoprazole Sodium18%Part D<11 patients+ 1 more class in this area
Anti-infectives
3.2%Macrolide Antimicrobial2.5%Azithromycin100%Part D≥42 patientsPenicillins with extended spectrum0.8%Amoxicillin-Clavulanate Potass100%Part D≥23 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Lung, Fat and Bone: Increased Adiponectin Associates with the Combination of Smoking-Related Lung Disease and Osteoporosis
Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation
2018 - The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes
Respiratory Research
2014 - Clinical phenotypes of chronic obstructive pulmonary disease and asthma: Recent advances
Journal of Allergy and Clinical Immunology
2013 - The Association of Adiponectin with Computed Tomography Phenotypes in Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine
2013
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”